Hyppää sisältöön
    • FI
    • ENG
  • FI
  • /
  • EN
OuluREPO – Oulun yliopiston julkaisuarkisto / University of Oulu repository
Näytä viite 
  •   OuluREPO etusivu
  • Oulun yliopisto
  • Avoin saatavuus
  • Näytä viite
  •   OuluREPO etusivu
  • Oulun yliopisto
  • Avoin saatavuus
  • Näytä viite
JavaScript is disabled for your browser. Some features of this site may not work without it.

Metabolic syndrome but not genetic polymorphisms known to induce NAFLD predicts increased total mortality in subjects with NAFLD (OPERA study)

Käräjämäki, Aki Juhani; Hukkanen, Janne; Kauma, Heikki; Kesäniemi, Y. Antero; Ukkola, Olavi (2019-12-18)

 
Avaa tiedosto
nbnfi-fe2020112693309.pdf (2.189Mt)
nbnfi-fe2020112693309_meta.xml (44.49Kt)
nbnfi-fe2020112693309_solr.xml (37.58Kt)
Lataukset: 

URL:
https://doi.org/10.1080/00365513.2019.1700428

Käräjämäki, Aki Juhani
Hukkanen, Janne
Kauma, Heikki
Kesäniemi, Y. Antero
Ukkola, Olavi
Informa
18.12.2019

Aki Juhani Käräjämäki, Janne Hukkanen, Heikki Kauma, Y. Antero Kesäniemi & Olavi Ukkola (2020) Metabolic syndrome but not genetic polymorphisms known to induce NAFLD predicts increased total mortality in subjects with NAFLD (OPERA study), Scandinavian Journal of Clinical and Laboratory Investigation, 80:2, 106-113, DOI: https://doi.org/10.1080/00365513.2019.1700428

https://rightsstatements.org/vocab/InC/1.0/
© 2019 Medisinsk Fysiologisk Forenings Forlag (MFFF). This is an Accepted Manuscript of an article published by Taylor & Francis in Scandinavian Journal of Clinical and Laboratory Investigation on 18 Dec 2019, available online: http://www.tandfonline.com/10.1080/00365513.2019.1700428.
https://rightsstatements.org/vocab/InC/1.0/
doi:https://doi.org/10.1080/00365513.2019.1700428
Näytä kaikki kuvailutiedot
Julkaisun pysyvä osoite on
https://urn.fi/URN:NBN:fi-fe2020112693309
Tiivistelmä

Abstract

Metabolic syndrome (MetS) and genetic polymorphisms PNPLA3 rs738409, TM6SF2 rs58542926 and MBOAT7 rs641738 are known inductors of non-alcoholic fatty liver disease (NAFLD). However, knowledge about how these affect the mortality of subjects with NAFLD is scarce. Therefore, we investigated the impact of MetS, PNPLA3 rs738409, TM6SF2 rs58542926 and MBOAT7 rs641738 on overall and cardiovascular disease (CVD) specific mortality among subjects with or without NAFLD. NAFLD diagnosis was based on liver ultrasound at the baseline. After this and other comprehensive examinations, 958 middle-aged Finns, 249 with NAFLD, were followed for 21 years. The mortality data was gathered from the National Death Registry. After multiple adjustments, the NAFLD individuals with MetS had increased risk of overall mortality as compared to the NAFLD subjects without MetS [2.054 (1.011–4.173, p = 0.046)]. However, PNPLA3 rs738409 [1.049 (0.650–1.692, p =0 .844)], TM6SF2 rs58542926 [0.721 (0.369–1.411, p = 0.340)] or MBOAT7 rs641738 [0.885 (0.543–1.439, p = 0.621)] did not affect the overall mortality. MetS was also a marker of increased risk of CVD mortality (15% vs. 2%, p =0.013) while genetic polymorphisms did not affect CVD mortality. In conclusion, MetS, but not the gene polymorphisms studied, predicts increased overall and CVD-specific mortality among NAFLD subjects.

Kokoelmat
  • Avoin saatavuus [38618]
oulurepo@oulu.fiOulun yliopiston kirjastoOuluCRISLaturiMuuntaja
SaavutettavuusselosteTietosuojailmoitusYlläpidon kirjautuminen
 

Selaa kokoelmaa

NimekkeetTekijätJulkaisuajatAsiasanatUusimmatSivukartta

Omat tiedot

Kirjaudu sisäänRekisteröidy
oulurepo@oulu.fiOulun yliopiston kirjastoOuluCRISLaturiMuuntaja
SaavutettavuusselosteTietosuojailmoitusYlläpidon kirjautuminen